Cargando…

Resensitization of Fosfomycin-Resistant Escherichia coli Using the CRISPR System

Antimicrobial resistance is a public health burden with worldwide impacts and was recently identified as one of the major causes of death in 2019. Fosfomycin is an antibiotic commonly used to treat urinary tract infections, and resistance to it in Enterobacteriaceae is mainly due to the metalloenzym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walflor, Haniel Siqueira Mortagua, Lucena, Aline Rodrigues Castro, Tuon, Felipe Francisco, Medeiros, Lia Carolina Soares, Faoro, Helisson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409345/ https://www.ncbi.nlm.nih.gov/pubmed/36012441 http://dx.doi.org/10.3390/ijms23169175

Ejemplares similares

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
por: Alrowais, Hind, et al.
Publicado: (2015)

Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa
por: Lorusso, Andre Bittencourt, et al.
Publicado: (2022)

Effect of Glycerol on Fosfomycin Activity against Escherichia coli
por: Ortiz-Padilla, Miriam, et al.
Publicado: (2022)

Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates
por: Ohkoshi, Yasuo, et al.
Publicado: (2017)

Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in Escherichia coli
por: Cattoir, Vincent, et al.
Publicado: (2020)

Fosfomycin Resistance in Escherichia coli Isolates from South Korea and in vitro Activity of Fosfomycin Alone and in Combination with Other Antibiotics
por: Seok, Hyeri, et al.
Publicado: (2020)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

Cross-Kingdom Extracellular Vesicles EV-RNA Communication as a Mechanism for Host–Pathogen Interaction
por: Munhoz da Rocha, Isadora Filipaki, et al.
Publicado: (2020)

Defects in DNA double‐strand break repair resensitize antibiotic‐resistant Escherichia coli to multiple bactericidal antibiotics
por: Revitt‐Mills, Sarah A., et al.
Publicado: (2022)

Detection of ESBL/AmpC-Producing and Fosfomycin-Resistant Escherichia coli From Different Sources in Poultry Production in Southern Brazil
por: Gazal, Luís Eduardo de Souza, et al.
Publicado: (2021)

Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018)

Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France
por: Benzerara, Yahia, et al.
Publicado: (2017)

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Escherichia coli Isolated in Clinical Urine Samples
por: Sorlozano-Puerto, Antonio, et al.
Publicado: (2020)

Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Wang, Lei, et al.
Publicado: (2019)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

Resensitizing AMPA receptors
por: Short, Ben
Publicado: (2019)

Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China
por: Li, Ya, et al.
Publicado: (2015)

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli
por: Zhanel, George G., et al.
Publicado: (2018)

In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal flora
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic Escherichia coli Clinical Isolates
por: Dzib-Baak, Haziel Eleazar, et al.
Publicado: (2022)

Inactivation of ackA and pta Genes Reduces GlpT Expression and Susceptibility to Fosfomycin in Escherichia coli
por: Hirakawa, Hidetada, et al.
Publicado: (2023)

Is nosocomial Escherichia coli bacteremia a predictive risk factor for mortality?
por: Tuon, Felipe F., et al.
Publicado: (2013)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

Resensitization in suspected penicillin allergy
por: Doña, Inmaculada, et al.
Publicado: (2022)

Modulation of Klebsiella pneumoniae Outer Membrane Vesicle Protein Cargo under Antibiotic Treatment
por: Lucena, Aline Castro Rodrigues, et al.
Publicado: (2023)

CRISPR-Cas adaptation in Escherichia coli
por: Mitić, Damjan, et al.
Publicado: (2023)

Determination of Extended-Spectrum β-Lactamases and AmpC Production in Uropathogenic Isolates of Escherichia coli and Susceptibility to Fosfomycin
por: Gupta, Varsha, et al.
Publicado: (2013)

Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli
por: Ríos, Esther, et al.
Publicado: (2022)

CRISPR/Cas Technologies and Their Applications in Escherichia coli
por: Dong, Huina, et al.
Publicado: (2021)

Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan
por: Tseng, Sung-Pin, et al.
Publicado: (2015)

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
por: Sojo-Dorado, Jesús, et al.
Publicado: (2022)

Dynamic mechanisms of CRISPR interference by Escherichia coli CRISPR-Cas3
por: Yoshimi, Kazuto, et al.
Publicado: (2022)

Identification of fosA10, a Novel Plasmid-Mediated Fosfomycin Resistance Gene of Klebsiella pneumoniae Origin, in Escherichia coli
por: Huang, Ying, et al.
Publicado: (2020)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

CRISPR-Cas Functional Module Exchange in Escherichia coli
por: Almendros, Cristóbal, et al.
Publicado: (2014)

CRISPR Content Correlates with the Pathogenic Potential of Escherichia coli
por: García-Gutiérrez, Enriqueta, et al.
Publicado: (2015)

Fosfomycin and breastfeeding
Publicado: (2020)

High incidence of fosfomycin-resistant uropathogenic E. coli among children
por: Abdelraheem, Wedad M., et al.
Publicado: (2023)

Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa
por: Kussmann, Manuel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ab4pi5c3kdd8m843go86327ho8